9 May 2025 • Young adults with steatotic liver disease face a heightened risk of early-onset cancer, according to a large Korean study.

Over a decade of follow-up, cancer risk was 19% higher in those with metabolic dysfunction-associated steatotic liver disease (MASLD), 12% higher in metabolic and alcohol-associated liver disease (MetALD), and 21% higher in alcohol-associated liver disease (ALD) compared to those without steatotic liver disease.

Obesity-related cancers were especially prevalent in MASLD and MetALD, with risk rising alongside cardiometabolic burden. Alcohol had a modest effect on overall cancer risk but varied by cancer type.

These findings highlight the importance of monitoring liver health and cardiometabolic factors to reduce cancer risk in young adults.

Source: CGH Journal | Read Full Story